Fatty acids, hyperinsulinemia, and insulin resistance: Which comes first?

Current Opinion in Lipidology

Volumn 5, Issue 3, 1994, Pages 166-174

  Björntorp, Per ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; FATTY ACID; GLUCOCORTICOID; GLYCEROL; HYDROCORTISONE; INSULIN RECEPTOR; TESTOSTERONE;

ADIPOSE TISSUE; ESTERIFICATION; FATTY ACID OXIDATION; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOLYSIS; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SKELETAL MUSCLE;

EID: 0028308844     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199405030-00003     Document Type: Review

References (53)

1. Groop P, Ferrannini E. Insulin Action and Substrate Competetion. Ballière's Clin Endocr Metab 1993, 7.1007-1032. An excellent comprehensive recent review. The authors discuss a number of important issues.
2. Arner P, Östman J: Mono- and Diacylglycerols in Human Adipose Tissue. Biochim Biophys Acta 1967, 369:209-221.
3. Campbell PJ, Carlson MG, Hill JO, Nurjan N: Regulation of Free-Fatty Acid Metabolism by Insulin in Humans: Role of Lipolysis and Esterification. Am J Physiol 1992, 263:E1063-1069. An important report discussing the problems of measuring adipose tissue lipolysis and re-esterification in vivo. This report illustrates the difficulties with this kind of measurement
4. Vaughan M, Steinberg D, Attman R: On the Interpretation of Studies Measuring Uptake and Esterification of [I-14C] Palmitic Acid by Rat Adipose Tissue, In Vitro. Biochim Biophys Acta 1964, 84:154-166.
5. Björntorp P: Metabolic Implication of Body Fat Distribution. Diabetes Care 1991, 14:1132-1143.
6. Björntorp P, Östman J: Human Adipose Tissue. Dynamics and Regulation. Adv Metab Dis 1971, 5:277-327.
7. Björntorp P, Bergman H, Varnauskas E, Lindholm N: Lipid Mobilization in Relation to Body Composition in Man. Metabolism 1969, 18:840-851.
8. Dohm GL, Topscott EB, Pories WJ, Dabbs DJ, Flickinger EG, Meelheim D, Fushiki T, Atkinson SM, Elton CW, Caro JF: An In Vitro Human Muscle Preparation Suitable for Metabolic Studies: Decreased Insulin Stimulation of Glucose Transport in Muscle from Morbidly Obese and Diabetic Subjects. J Clin Invest 1988, 82:486-494.
9. Golay A, Felber JP, De Fronzo RA, Ferrannini E: Metabolic-Basis of Obesity and Non-Insulin Dependent Diabetes Mellitus. Diab Metab Rev 1988, 4:727-747.
10. Salans LB, Knittle J, Hirsch J: The Role of Adipose Cell Size and Adipose Tissue Insulin Sensitivity in the Carbohydrate Intolerance of Human Obesity. J Clin Invest 1968, 47:153-159.
11. Kissebah A, Peiris A: Biology of Regional Body Fat Distribution: Relationship to Non-Insulin-Dependent Diabetes Mellitus. Diabetes Metab Rev 1989, 5:83-109.
12. Björntorp P: Adipose Tissue Distribution and Function. Int J Obesity 1991, 15.67-81.
13. Divertie GD, Jensen MD, Miles JM: Stimulation of Lipolysis in Humans by Physiological Hypercortisolemia. Diabetes 1991. 40:1228-1232.
14. Carter-Su C, Okamoto K: Effect of Insulin and Glucocorticoids on Glucose Transporters in Rat Adipocytes. Am J Physiol 1987, 252:E441-E453.
15. Cigolini M, Smith U: Human Adipose Tissue in Culture. VIII. Studies on the Insulin-Antagonistic Effect of Glucocorticoids. Metabolism 1979, 28:502-510.
16. Guillaume-Gentil C, Assimacopoulos-Jeannet F, Jeaurenaud B: Involvement of Non-Esterified Fatty Acid Oxidation in Glucocorticoid-Induced Peripheral Insulin Resistance in Rats. Diabetologia 1993, 36:899-906. This important report describes the effects of glucocorticoids on systemic insulin resistance, suggesting that FFA are the responsible factor.
17. Ekstrand A, Saloranta C, Ahonen J, Grönhagen-Riska C, Groop L: Reversal of Steroid-Induced Insulin Resistance by a Nicotinic-Acid Derivative in Man. Metabolism 1992, 41:692-697.
18. Mårin P, Darin N, Amemiya T, Andersson B, Jern S, Björntorp P: Cortisol Secretion in Relation to Body Fat Distribution in Obese Premenopausal Women. Metabolism 1992, 41:882-886.
19. Bray G: Autonomic and Endocrine Factors in the Regulation of Energy Balance. Fed Proc 1986, 45:1404-1410.
20. Goodman HM, Gorin E, Honeyman TW: Biochemical Basis for the Lipolytic Effect of Growth Hormone. In Human Growth Hormone, Progress and Challenges. Edited by Underwood LE. New York: M Dekker Press; 1988:75-111.
21. Appel B, Fried SK: Effects of Insulin and Dexamethasone on Lipoprotein Lipase in Human Adipose Tissue. Am J Physiol 1992, 26:E695-E699.
22. Ottosson M, Vikman-Adolfsson K, Enerbäck S, Bengtsson-Olivecrona G, Björntorp P: The Effects of Cortisol on the Regulation of Lipoprotein Lipase Activity in Human Adipose Tissue. 1993 (submitted)
23. Rebuffé-Scrive M, Lundholm K, Björntorp P: Glucocorticoid Hormone Binding to Human Adipose Tissue. Eur J Clin Invest 1985, 15.267-271
24. Baynes C, Henderson AD, Hughes CL, Richmond W, Johnston DG, Elkeles RS: Determinants of Mild Fasting Hypertriglyceridaemia in Non-Insulin-Dependent Diabetes. J Intern Med 1991, 229:267-273.
25. Skowronski R, Hollenbeck CB, Varasteh BB, Chen Y-DI, Reaven GM: Regulation of Non-Esterified Fatty Acid and Glycerol Concentration by Insulin in Normal Individuals and Patients with Type 2 Diabetes. Diabet Med 1991, 8:330-333.
26. Cavallo-Perin P, Bruno A, Cassader M, Cesco L, Gruden G, Pagano G: The Glucoregulatory and Antilipolytic Actions of Insulin in Abdominal Obesity with Normal or Impaired Glucose Tolerance: An In Vivo and In Vitro Study. Eur J Clin Invest 1992, 22:725-731.
27. Del Prato S, Enzi G, Vigili de Kreutzenberg S, Lisato G, Riccio A, Maifreni L, Iori E, Zurlo F, Sergi G, Tiengo A. Insulin Regulation of Glucose and Lipid Metabolism in Massive Obesity. Diabetologia 1990, 33:228-236.
28. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA: The Role of the Free Fatty Acid Metabolism in the Pathogenesis of Insulin Resistance in Obesity and Non Insulin-Dependent Diabetes Meilitiis. J Clin Endocrinol Metab 1991, 72:96-107.
29. Bonadonna RC, Groop L, Kraemer N, Ferrannini E, Del Prato S, DeFronzo RA: Obesity and Insulin Resistance in Humans: A Dose-Response Study. Metabolism 1990, 39:452-459.
30. Howard B, Klimies J, Vasquez B, Brady D, Nagulesparan M, Unger RH: The Antilipolytic Action of Insulin in Obese Subjects with Resistance to Its Glucoregulatory Action. J Clin Endocrinol Metab 1984, 58:541-551.
31. Chen Y-DI, Golay A, Swislocki ALM, Reaven GM. Resistance to Insulin Suppression of Plasma Free Fatty Acid Concentrations and Insulin Stimulation of Glucose Uptake in Noninsulin- Dependent Diabetes Mellitus. J Clin Endocrinol Melab 1987, 64:17-21.
32. Zancanaro C, Cigolini M, Bonora E, Moghetti P. Querena M, Muggeo M: Glucose and Insulin Suppression of Plasma Free Fatty Acids in Obese Subjects with Normal Glucose Tolerance or Mild, Newly Diagnosed Type 2 (Non-Insulin-Dependent) Diabetes. J Endocrinol Invest 1990, 13:55-59.
33. Felber JP, Golay A, Felley C, Jecquier E: Regulation of Glucose Storage in Obesity and Diabetes: Metabolic Aspects. Diabetes Metab Rev 1988, 4:691-700.
34. Björntorp P: Androgens, the Metabolic Syndrome and Non-Insulin Dependent Diabetes Mellitus. NY Acad Sci 1993, 676:242- 252. Evidence suggesting an important role for androgens in the regulation of insulin sensitivity in women and men. This is a previously neglected area of potentially great importance.
35. Holmäng A, Björntorp P, Rippe B: Tissue Uptake of Insulin and Insulin in Red and White Skeletal Muscle In Vivo. Am J Physiol 1992, 263:1171-1176.
36. Lindstedt G, Lundberg PA, Lapidus L, Lundgren H, Bengtsson C, Björntorp P: Low Sex-Hormone-Binding Globulin Concentration as Independent Risk Factor for Development of NIDDM 12-Yr Follow-up of Population Study of Women in Gothenburg, Sweden. Diabetes 1991, 40:123-128.
37. Björntorp P: Hyperandrogenicity in Women - A Prediabetic Condition? J Intern Med 1993, 234:579-583.
38. Randle PJ, Garland PB, Hales CN, Newsholme EA: The Glucose-Fatty Acid Cycle. Its Role in Insulin Sensitivity and the Metabolic Disturbances of Diabetes Mellitus. Lancet 1963, I.785-789.
39. Wititsuwannakul D, Ki-Han: Mechanism of Palmityl Coenzyme A Inhibition of Liver Glycogen Synthase. J Biol Chem 1977, 252:7812-7817.
40. Mårin P, Andersson B, Ottosson M, Olbe L, Chowdhury B, Kvist H, Holm G, Sjöström L, Björntorp P: The Morphology and Metabolism of Intraabdominal Adipose Tissue in Men. Metabolism 1992, 41:1242-1248.
41. Björntorp P: 'Portal' Adipose Tissue as a Generator of Risk Factors for Cardiovascular Disease and Diabetes. Arteriosclerosis 1990, 10:493-496.
42. Coppack SW, Evans RD, Fischer RM, Frayn KN, Gibbons GF, Humphreys SM, Kirk MJ, Potts JL, Hockaday TDR: Adipose Tissue Metabolism in Obesity: Lipase Action In Vivo Before and After a Mixed Meal. Metabolism 1992, 41:264-272.
43. Arner P, Bolinder J, Engfeldt P, Östman J: The Antilipolytic Effect of Insulin in Human Adipose Tissue in Obesity, Diabetes Mellitus, Hyperinsulinemia, and Starvation. Metabolism 1981, 30:753-760.
44. Kashiwagi A, Bogardus C, Lillioja S, Huecksteadt TP, Brady D, Verso MA. Foley JE: In Vitro Insensitiviry of Glucose Transport and Antilipolysis to Insulin Due to Receptor and Postreceptor Abnormalities in Obese Pima Indians with Normal Glucose Tolerance. Metabolism 1984, 33:772-777.
45. Jacobsson B, Smith U: Effect of Cell Size on Lipolysis and Antilipolytic Action of Insulin in Human Fat Cells. J Lipid Res 1972, 13:651-654.
46. Jacobsson B, Holm G, Björntorp P, Smith U: Influence of Cell Size on the Effects of Insulin and Noradrenaline on Human Adipose Tissue. Diabetologia 1976, 12:69-74.
47. Fulcher GR, Walker M, Catalano C, Agius L, Alberti KGMM: Metabolic Effects of Suppression of Non-Esterified Fatty Acids Levels with Acipimox in Obese NIDDM Subjects. Diabetes 1992, 41:1400-1408. An important report on the effects of suppression of FFA levels on glucose metabolism in NIDDM during a relatively long period of time.
48. Saloranta C, Taskinen M-R, Widen E, Härkonen M, Melander A, Groop L: Metabolic Consequences of Substained Suppression of Free Fatty Acids by Acipimox in Patients with NIDDM. Diabetes 1993, 42:1559-1566.
49. Fulcher GR, Walker M, Farrer M, Johnson AS, Alberti KGMM: Acipimox Increases Glucose Disposal in Normal Man Independent of Changes in Plasma Non-Esterined Fatty Acid Concentration and Whole-Body Lipid Oxidation Rate. Metabolism 1993, 42:308-314.
50. Reaven GM, Chang H, Ho H, Jeng C-Y, Hoffman BB. Lowering of Plasma Glucose in Diabetic Rats by Antilipolytic Agents. Am J Physiol 1988, 254:E23-30.
51. Reaven GM, Chang H, Hoffman BB: Additive Hypoglycemic Effects of Drugs that Modify Free-Fatty Acid Metabolism by Different Mechanisms in Rats with Streptozotocin-Induced Diabetes. Diabetes 1988, 32:28-32.
52. Del Prato S, Bonadonna RC, Bonora E, Gulh G, Solini A, Shank M, DeFronzo KA: Characterization of Cellular Defects of Insulin Action in Type 2 (Non-Insulin-Dependent) Diabetes Mellitus. J Clin Invest 1993, 91:484-494. A detailed, comprehensive study of metabolic defects in NIDDM The authors examine in great detail various possible defects and the effects of insulin.
53. Björntorp P. Visceral Obesity: A 'Civilization Syndrome'. Obesity Res 1993, 1:206-222. A review of endocrine perturbations in visceral obesity, a condition characterized by elevated FFA concentrations, insulin resistance, and hyperinsulinemia.